Ayutara ...
Precision Medicine Innovation

OncoPulse Pipeline

Bridging molecular discovery and clinical excellence — advancing radioligand therapies for global impact.

Explore Pipeline

Pipeline Overview

From discovery to delivery — Ayutara’s integrated innovation pipeline accelerates next-generation therapies.

End-to-End Development Engine

Our pipeline connects discovery biology, clinical strategy, and patient data science in one unified system.

  • Preclinical: AI-guided molecule optimization
  • Phase I: Human safety and dose evaluation
  • Phase II: Proof-of-concept trials
  • Phase III: Global registration
Explore Full Pipeline
Pipeline

Innovation Highlights

Integrating data-driven insights, clinical precision, and breakthrough science.

AI-Driven Discovery

Using deep learning to identify novel targets faster.

Next-Gen Radioligands

High affinity with minimal off-target effects.

Smart Clinical Insights

Data integration for continuous improvement.

Research Pipeline

From target validation to clinical application.

Discovery

Target validation and early lead identification using AI-assisted modeling.

Preclinical

Pharmacology, safety, and biodistribution studies in optimized models.

Clinical Phase I

First-in-human studies evaluating safety, tolerability, and biodynamics.

Phase II/III

Global clinical trials demonstrating efficacy and long-term benefits.

Approval & Launch

Regulatory submission and commercialization of breakthrough therapies.

Collaborative Ecosystem

Connecting innovators, researchers, clinicians, and global communities.

Academia
Research
Biotech
Clinical
Global Access

The Future Horizon

Exploring the next frontier of precision medicine.

AI Integration
Radioligand Research
Global Expansion
Patient-Centric